Skip to main content
Fig. 5 | Breast Cancer Research

Fig. 5

From: Metabolomics assisted by transcriptomics analysis to reveal metabolic characteristics and potential biomarkers associated with treatment response of neoadjuvant therapy with TCbHP regimen in HER2 + breast cancer

Fig. 5

Thirteen metabolites exhibited permanent changes between non-pCR patients and pCR patients during the therapy term. (A) Venn plot was performed to identify metabolites that were persistently and differentially expressed between non-pCR patients and pCR patients (A vs. D, B vs. E and C vs. F). (B-N) Violin plots depicting the levels of 13 metabolites between non-pCR and pCR groups at different treatment time points. The Kruskal Wallis test was used to compare the metabolite expression difference among multiple groups

Back to article page